Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 33

Sort by

Sort Order Select

Journal Articles

The Transcriptomic Landscape of NUP98-Rearranged Pediatric Acute Myeloid Leukemia

Jenny L. Smith, MSc, MD, Eline J.M. Bertrums, Rhonda E. Ries, MA, Fabiana Ostronoff, MD, Amanda R. Leonti, MS, Scott N. Furlan, MD, Bianca F. Goemans, MD PhD, Soheil Meshinchi, MDPhD

Blood (2020) 136 (Supplement 1): 36–37.

https://doi.org/10.1182/blood-2020-138935

Published: 2020

Journal Articles

The Molecular Characteristics and Clinical Relevance of NUP98 -Other Translocations in Pediatric Acute Myeloid Leukemia

Eline J.M. Bertrums, Jenny L. Smith, MSc, MD, Rhonda E. Ries, MA, Todd A. Alonzo, PhD, Fabiana Ostronoff, MD, Gertjan J.L. Kaspers, Prof. MD PhD, Henrik Hasle, PhD, Christian M. Zwaan, Betsy A Hirsch, PhD, Susana C. Raimondi, PhD, Todd M. Cooper, DO, Richard Aplenc, MD PhD, Alan S. Gamis, MD MPH, Edward A. Kolb, MD, Bianca F. Goemans, MD PhD, Soheil Meshinchi, MDPhD

Blood (2020) 136 (Supplement 1): 36–37.

https://doi.org/10.1182/blood-2020-137537

Published: 2020

Journal Articles

Genomic Subtypes of Nucleophosmin (NPM1) Mutations Are Associated with Clinical Outcome in AML - a COG and SWOG Intergroup Collaboration

Dalia Selim, MD, Todd A. Alonzo, PhD, Megan Othus, PhD, Robert Gerbing, BS, Fabiana Ostronoff, MD, Katherine Tarlock, MD, Matthew A. Kutny, MD, Richard Aplenc, MD PhD, E. Anders Kolb, MD, Jerald P. Radich, MD, Frederick R. Appelbaum, MD, Alan S. Gamis, MD MPH, Derek L. Stirewalt, Soheil Meshinchi, MD PhD

Blood (2016) 128 (22): 285.

https://doi.org/10.1182/blood.V128.22.285.285

Published: 2016

Journal Articles

Rearrangements in Nucleoporin Family of Genes in Childhood Acute Myeloid Leukemia: A Report from Children Oncology Group and NCI/COG Target AML Initiative

Blood (2015) 126 (23): 169.

https://doi.org/10.1182/blood.V126.23.169.169

Published: 2015

Journal Articles

Defining the Genomic Make up of Acute Myeloid Leukemia in Adolescents and Young Adults (AYA): Report from COG AAML03P1, AAML531 and SWOG S0106

Fabiana Ostronoff, MD, Todd A. Alonzo, PhD, Megan Othus, PhD, Matthew A. Kutny, MD, Robert B. Gerbing, MA, Jerald P. Radich, MD, Harry P Erba, MD PhD, Frederick R. Appelbaum, MD, E. Anders Kolb, MD, Alan S. Gamis, MD MPH, Derek L. Stirewalt, MD, Soheil Meshinchi, MD PhD

Blood (2015) 126 (23): 2576.

https://doi.org/10.1182/blood.V126.23.2576.2576

Published: 2015

Journal Articles

Randomized Study of Liposomal Cytarabine and Daunorubicin (CPX-351) for Adults with Untreated High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) at High Risk of Treatment-Related Mortality

Roland B. Walter, MD PhD MS, Kaysey F. Orlowski, Morgan A. Powell, BS, Pamela S. Becker, MD PhD, Paul C. Hendrie, MD PhD, Fabiana Ostronoff, MD, Elizabeth M. Ranker, PA-C, Megan Othus, PhD, Arthur C. Louie, MD, Elihu H. Estey, MD

Blood (2014) 124 (21): 994.

https://doi.org/10.1182/blood.V124.21.994.994

Published: 2014

Journal Articles

Mitoxantrone, Etoposide, and Cytarabine (MEC) Following Epigenetic Priming with Decitabine in Adults with Relapsed/Refractory Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS): A Phase 1 Study

Anna B. Halpern, MD, Elihu H. Estey, MD, Megan Othus, PhD, Kaysey F. Orlowski, Morgan A. Powell, BS, Tara L. Chen, PharmD, Pamela S. Becker, MD PhD, Bart L. Scott, MD, Paul C. Hendrie, MD PhD, Fabiana Ostronoff, MD, Elizabeth M. Ranker, PA-C, Mazyar Shadman, MD MPH, Derek L. Stirewalt, MD, Roland B. Walter, MD PhD MS

Blood (2014) 124 (21): 3730.

https://doi.org/10.1182/blood.V124.21.3730.3730

Published: 2014

Journal Articles

Feasibility Trial of Individualized Therapy for Relapsed or Refractory Acute Myeloid Leukemia Based on a High Throughput in Vitro Drug Sensitivity Assay

Pamela S. Becker, MD PhD, Vivian Oehler, MD, Elihu H. Estey, MD, Timothy Martins, PhD, Andrea Perdue, PA-C, Jodie David, RN, Sylvia Chien, Paul C. Hendrie, MD PhD, Fabiana Ostronoff, MD, C. Anthony Blau, MD

Blood (2014) 124 (21): 3748.

https://doi.org/10.1182/blood.V124.21.3748.3748

Published: 2014

Journal Articles

NUP98/NSD1 and FLT3/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG report

Fabiana Ostronoff, Megan Othus, Robert B. Gerbing, Michael R. Loken, Susana C. Raimondi, Betsy A. Hirsch, Beverly J. Lange, Stephen Petersdorf, Jerald Radich, Frederick R. Appelbaum, Alan S. Gamis, Todd A. Alonzo, Soheil Meshinchi

Blood (2014) 124 (15): 2400–2407.

https://doi.org/10.1182/blood-2014-04-570929

Published: 2014

Includes: Supplemental data

Journal Articles

Impact Of Cytarabine Dose In The Induction Regimen On The Outcome Of Patients With Newly Diagnosed Acute Myeloid Leukemia With Or Without NPM1 and/Or FLT3 Mutations: A SWOG and MD Anderson Cancer Center Report

Farhad Ravandi, MD, Megan Othus, PhD, Stefan H. Faderl, MD, Derek L. Stirewalt, MD, Sherry R. Pierce, RN, BS, Gautam Borthakur, MD, John Godwin, MD, Jeanne E. Anderson, MD, Stephen Petersdorf, MD, Jorge E. Cortes, MD, Fabiana Ostronoff, MD, Era Pogosova-Agadijanyan, MD, Frederick R. Appelbaum, MD, Hagop M. Kantarjian, MD, Elihu H. Estey, MD

Blood (2013) 122 (21): 2686.

https://doi.org/10.1182/blood.V122.21.2686.2686

Published: 2013

Journal Articles

Prognostic Significance Of NPM1 mutations In The Absence Of FLT3 -ITD in Older Patients With AML: A SWOG Report

Fabiana Ostronoff, MD, Megan Othus, PhD, Soheil Meshinchi, MD, PhD, John E. Godwin, MD, MS, Kenneth J. Kopecky, PhD, Alan List, MD, Vivian G. Oehler, MD, Stephen Petersdorf, MD, Era L. Pogosova-Agadjanyan, Jerald Radich, MD, Cheryl L. Willman, MD, Frederick R. Appelbaum, MD, Derek L. Stirewalt, MD

Blood (2013) 122 (21): 1315.

https://doi.org/10.1182/blood.V122.21.1315.1315

Published: 2013

Journal Articles

NUP98/NSD1 Translocation Further Risk-Stratifies Patients With FLT3/ITD In Acute Myeloid Leukemia: A Report From Children’s Oncology Group and SWOG

Fabiana Ostronoff, MD, Megan Othus, PhD, Robert B. Gerbing, MA, Michael R. Loken, PhD, Susana C Raimondi, PhD, Betsy A. Hirsch, PhD, Beverly J. Lange, MD, Stephen Petersdorf, MD, Jerald Radich, MD, Frederick R. Appelbaum, MD, Alan S. Gamis, MD, MPH, Todd A. Alonzo, PhD, Soheil Meshinchi, MD, PhD

Blood (2013) 122 (21): 488.

https://doi.org/10.1182/blood.V122.21.488.488

Published: 2013

Journal Articles

RNA-Sequencing Unveils Cryptic Fusions in Patients with Acute Myeloid Leukemia

Fabiana Ostronoff, MD, Matthew Fitzgibbon, Martin McIntosh, Rhonda E. Ries, MA, Alan S. Gamis, MD, MPH, Todd A. Alonzo, PhD, Frederick R. Appelbaum, MD, Derek L. Stirewalt, MD, Soheil Meshinchi, MD, PhD

Blood (2012) 120 (21): 1278.

https://doi.org/10.1182/blood.V120.21.1278.1278

Published: 2012

Journal Articles

A Scoring System for Prediction of FLT3 -ITD Positivity in Patients with Newly Diagnosed Acute Myeloid Leukemia.

Blood (2012) 120 (21): 2590.

https://doi.org/10.1182/blood.V120.21.2590.2590

Published: 2012

Journal Articles

Cryptic NUP98/NSD1 Translocations Are Highly Prevalent in FLT3/ITD-Positive Acute Myeloid Leukemia and Lead to High Rate of Induction Failure. Report From Children's Oncology Group

Fabiana Ostronoff, MD, Todd A. Alonzo, PhD, Robert B. Gerbing, M.A., Michael R. Loken, PhD, Laura Pardo, Richard Aplenc, MD, PhD, Lillian Sung, MD, PhD, Susana C. Raimondi, Betsy A. Hirsch, PhD, Samir Kahwash, MD, Amy Heerema-McKenney, MD, Laura Winter, PharmD, Kathleen Glick, CCRP, Patti Byron, MSN, RN, Robert S. Lavey, MD, Stella M. Davies, MBBS, PhD, Franklin O. Smith, MD, Alan S. Gamis, MD, MPH, Soheil Meshinchi, MD, PhD

Blood (2012) 120 (21): 529.

https://doi.org/10.1182/blood.V120.21.529.529

Published: 2012

Journal Articles

Multi-Institutional Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) for HCT Outcomes

Mohamed L. Sorror, MD, MSc, Fabiana Ostronoff, MD, Rainer Storb, MD, Smita Bhatia, MD, MPH, Richard T. Maziarz, MD, Michael A. Pulsipher, MD, Michael T. Maris, MD, H. Joachim Deeg, M.D., Paul J Martin, MD, Frederick R. Appelbaum, MD, David G. Maloney, MD, PhD, Brenda M Sandmaier, MD, Barry Storer, PhD

Blood (2011) 118 (21): 145.

https://doi.org/10.1182/blood.V118.21.145.145

Published: 2011

Journal Articles

Interaction of Age and Comorbidities and Their Impacts on Hematopoietic Cell Transplantation (HCT) Outcomes

Fabiana Ostronoff, MD, Barry Storer, PhD, Rainer Storb, MD, Smita Bhatia, MD, MPH, Richard T. Maziarz, MD, Michael A. Pulsipher, MD, Michael T. Maris, MD, H. Joachim Deeg, M.D., Paul J. Martin, MD, Frederick R. Appelbaum, M.D., David G. Maloney, MD, PhD, Brenda M. Sandmaier, MD, Mohamed L. Sorror, MD, MSc

Blood (2011) 118 (21): 665.

https://doi.org/10.1182/blood.V118.21.665.665

Published: 2011

Journal Articles

KIT Mutations Are Rare Among Elderly AML Patients: A SWOG Report

Fabiana Ostronoff, MD, Megan Othus, PhD, Phoenix A. Ho, MD, Stephen H. Petersdorf, MD, Jeanne E. Anderson, MD, John E. Godwin, MD, MS, Cheryl L Willman, MD, Jerald P. Radich, MD, Frederick R. Appelbaum, MD, Derek L. Stirewalt, MD, Soheil Meshinchi, MD, PhD

Blood (2011) 118 (21): 2510.

https://doi.org/10.1182/blood.V118.21.2510.2510

Published: 2011

Journal Articles

Umbilical Cord Blood Transplantation in Patients with Hematological Malignancies Using a Non-ATG Containing Reduced Intensity Preparative Regimen

Fabiana Ostronoff, MD, Filippo Milano, MD, PhD, Ted Gooley, Jonathan Gutman, MD, Peter A. McSweeney, MD, Finn Petersen, M.D., Brenda M. Sandmaier, MD, Rainer Storb, MD, Colleen Delaney, MD

Blood (2011) 118 (21): 1943.

https://doi.org/10.1182/blood.V118.21.1943.1943

Published: 2011

Journal Articles

Prevalence and Clinical Implications of IDH2 R140 and R172 Mutations in Older Adults with AML: A Report From SWOG,

Phoenix A. Ho, MD, Megan Othus, PhD, Fabiana Ostronoff, MD, Stephen H. Petersdorf, MD, Jeanne E. Anderson, MD, John E. Godwin, MD, MS, Cheryl L Willman, MD, Jerald P. Radich, MD, Frederick R. Appelbaum, MD, Derek L. Stirewalt, MD, Soheil Meshinchi, MD, PhD

Blood (2011) 118 (21): 3516.

https://doi.org/10.1182/blood.V118.21.3516.3516

Published: 2011

NARROW

The Transcriptomic Landscape of NUP98-Rearranged Pediatric Acute Myeloid Leukemia

The Molecular Characteristics and Clinical Relevance of NUP98 -Other Translocations in Pediatric Acute Myeloid Leukemia

Genomic Subtypes of Nucleophosmin (NPM1) Mutations Are Associated with Clinical Outcome in AML - a COG and SWOG Intergroup Collaboration

Rearrangements in Nucleoporin Family of Genes in Childhood Acute Myeloid Leukemia: A Report from Children Oncology Group and NCI/COG Target AML Initiative

Defining the Genomic Make up of Acute Myeloid Leukemia in Adolescents and Young Adults (AYA): Report from COG AAML03P1, AAML531 and SWOG S0106

Randomized Study of Liposomal Cytarabine and Daunorubicin (CPX-351) for Adults with Untreated High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) at High Risk of Treatment-Related Mortality

Mitoxantrone, Etoposide, and Cytarabine (MEC) Following Epigenetic Priming with Decitabine in Adults with Relapsed/Refractory Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS): A Phase 1 Study

Feasibility Trial of Individualized Therapy for Relapsed or Refractory Acute Myeloid Leukemia Based on a High Throughput in Vitro Drug Sensitivity Assay

NUP98/NSD1 and FLT3/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG report

Impact Of Cytarabine Dose In The Induction Regimen On The Outcome Of Patients With Newly Diagnosed Acute Myeloid Leukemia With Or Without NPM1 and/Or FLT3 Mutations: A SWOG and MD Anderson Cancer Center Report

Prognostic Significance Of NPM1 mutations In The Absence Of FLT3 -ITD in Older Patients With AML: A SWOG Report

NUP98/NSD1 Translocation Further Risk-Stratifies Patients With FLT3/ITD In Acute Myeloid Leukemia: A Report From Children’s Oncology Group and SWOG

RNA-Sequencing Unveils Cryptic Fusions in Patients with Acute Myeloid Leukemia

A Scoring System for Prediction of FLT3 -ITD Positivity in Patients with Newly Diagnosed Acute Myeloid Leukemia.

Cryptic NUP98/NSD1 Translocations Are Highly Prevalent in FLT3/ITD-Positive Acute Myeloid Leukemia and Lead to High Rate of Induction Failure. Report From Children's Oncology Group

Multi-Institutional Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) for HCT Outcomes

Interaction of Age and Comorbidities and Their Impacts on Hematopoietic Cell Transplantation (HCT) Outcomes

KIT Mutations Are Rare Among Elderly AML Patients: A SWOG Report

Umbilical Cord Blood Transplantation in Patients with Hematological Malignancies Using a Non-ATG Containing Reduced Intensity Preparative Regimen

Prevalence and Clinical Implications of IDH2 R140 and R172 Mutations in Older Adults with AML: A Report From SWOG,

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only